Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study.

Talebi, Seyed Saman; Ghasemi, Mehran; Etminani-Esfahani, Maryam; Mohammadi, Younes; Haddadi, Rasool

Talebi, Seyed Saman; Ghasemi, Mehran; Etminani-Esfahani, Maryam; Mohammadi, Younes; Haddadi, Rasool.

Afiliação

Talebi SS; Department of Internal Medicine, School of Medicine, Shahid Beheshti Medical Educational Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Ghasemi M; Department of Pharmacology and Toxicology, School of Pharmacy, Herbal Medicine and Natural Product Research Center, Hamadan University of Medical Sciences and Health Services, Hamadan, Iran.
Etminani-Esfahani M; Department of Clinical Pharmacy and Services, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Mohammadi Y; Department of Epidemiology, School of Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Haddadi R; Department of Pharmacology and Toxicology, School of Pharmacy, Herbal Medicine and Natural Product Research Center, Hamadan University of Medical Sciences and Health Services, Hamadan, Iran. haddadi.rasool@gmail.com.

Pharmacol Rep ; 74(6): 1296-1305, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35997951

Assuntos

COVID-19; Carnitina; Humanos; Carnitina/uso terapêutico; Projetos Piloto

Palavras-chave

C-reactive protein; COVID-19; Clinical outcome; L-carnitine; Para-clinical examination

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carnitina / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Pharmacol Rep Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google